Compare QUBT & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QUBT | BLFS |
|---|---|---|
| Founded | 2001 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2019 | 2013 |
| Metric | QUBT | BLFS |
|---|---|---|
| Price | $7.85 | $36.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $17.50 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 6.3M | 826.2K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 84.93 | 77.27 |
| EPS | N/A | ★ 0.94 |
| Revenue | $682,000.00 | ★ $96,214,000.00 |
| Revenue This Year | $3,210.56 | $19.73 |
| Revenue Next Year | $51.26 | $17.82 |
| P/E Ratio | ★ N/A | $37.18 |
| Revenue Growth | ★ 82.84 | 16.97 |
| 52 Week Low | $6.18 | $17.86 |
| 52 Week High | $25.84 | $38.10 |
| Indicator | QUBT | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 45.16 | 54.66 |
| Support Level | $7.57 | $23.66 |
| Resistance Level | $9.25 | $38.10 |
| Average True Range (ATR) | 0.34 | 0.90 |
| MACD | -0.02 | -0.39 |
| Stochastic Oscillator | 29.57 | 31.00 |
Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.